References
- Arkwright P. D., David T. J. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL172) is associated with improvement in atopic dermatitis in children with moderate to severe disease. J Allergy Clin Immunol 2001; 107: 531–4
- Arkwright P. D., David T. J. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br J Dermatol 2003; 149: 1029–34
- Hadley E. A., Smillie F. I., Turner M. A., Custovic A., Woodcock A. Effect of Mycobaterium vaccae on cytokine responses in children with atopic dermatitis. Clin Exp Immunol 2005; 140: 101–8
- Berth‐Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score in simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135((suppl 48))25–30
- Gruber C., Meinlschmidt G., Bergman R., Wahn U., Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr Allergy Immunol 2002; 13: 177–81
- Gruber C., Illi S., Lau S., Nickel R., Forster J., Kamin W., et al. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 2003; 111: e282–8